Sameer Sirohi

Sameer Sirohi has been working in the field of science since 2011. Sameer began their career as a Research Scientist at Topivert Pharma Limited and then moved on to become a Scientist at Cancer Research UK (CRUK) in 2019. Currently, they are a Senior Scientist at Mestag Therapeutics.

Sameer Sirohi began their educational career at the International School of Lausanne, where they obtained an International Baccalaureate Diploma (Bilingual: En/Fr) in 2007. Sameer then attended Imperial College London, where they obtained a Bachelor of Science in Biology/Biological Sciences, General in 2010. Sameer continued their studies at Imperial College London, earning a Master of Science in Immunology in 2011. In 2018, they obtained a PRINCE2 Practitioner certification in Project Management from AXELOS Global Best Practice. Sameer also holds certifications in Data Integrity and Clinical Trials Regulation (CTR) and Good Clinical Practice (GCP) for Sponsors from the Institute of Clinical Research.